Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05153_nanopub.RA0m5v8XYefly3MT0ox3U0S56k5NhiZAmgsCP_pJtYIPg#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05153 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05153 label "XL184 [drugbank:DB05153]" assertion.
- drugbank:DB05153 seeAlso DB05153 assertion.
- drugbank:DB05153 identifier "drugbank:DB05153" assertion.
- drugbank:DB05153 description "XL184 is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. XL184 strongly binds to and inhibits several tyrosine receptor kinases. Specifically, XL184 appears to have a strong affinity for the hepatocyte growth factor receptor (Met) and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in inhibition of tumor growth and angiogenesis, and tumor regression. This agent has also been shown to inhibit mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (Flt3) and tyrosine-protein kinase receptor (Tie-2)." assertion.
- drugbank:DB05153 title "XL184" assertion.
- drugbank:DB05153 bio2rdf_vocabulary:identifier "DB05153" assertion.
- drugbank:DB05153 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05153 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05153" assertion.
- drugbank:DB05153 bio2rdf_vocabulary:x-identifiers.org DB05153 assertion.
- drugbank:DB05153 drugbank_vocabulary:drugbank-id "DB05153" assertion.
- drugbank:DB05153 drugbank_vocabulary:x-cas cas: assertion.